Menopause: new frontiers in the treatment of urogenital atrophy.

Published on Jan 1, 2018in European Review for Medical and Pharmacological Sciences3.024
· DOI :10.26355/EURREV_201801_14211
Casarotti Ga1
Estimated H-index: 1
,
Chiodera P1
Estimated H-index: 1
,
Tremolada C1
Estimated H-index: 1
Source
Abstract
OBJECTIVE: Urogenital atrophy is a degenerative process that may occur during menopause causing debilitating disorders and painful symptomatology. Estrogen therapy slows the onset of atrophy, but it requires ongoing therapy to maintain its effectiveness. To mitigate the degenerative evolutions associated with menopause, patients may benefit from new therapeutic approaches, such as the use of mesenchymal stem cells. Among the many sources, the adipose tissue is considered one of the smartest, due to its abundance and easy access. This study investigated the feasibility and potential benefits of using an autologous adipose tissue to treat the symptoms of urogenital atrophy. PATIENTS AND METHODS: In 2014, the first three women affected by post-menopausal urogenital atrophy were treated with injections of autologous and micro-fragmented adipose tissue (Lipogems®). Clinical outcomes were determined at 3, 6, 9, 12, 18, 24, and 36 months by evaluating vaginal dryness, burning, itching, stranguria, sensitivity, and dyspareunia. Pre- and 36 months post-op biopsies and vaginal discharge were also collected. RESULTS: The three women reported a significant improvement of the symptoms at 6 months with complete resolution at 9 months. This benefit, subjectively reported and confirmed by clinical evaluation, remained constant without recurrence at least until 36 months. Immunohistochemical analysis revealed a total recovery of vaginal vitality with production of glycogen, vasculature hyperplasia and regeneration of the epithelium and subcutaneous tissue at 36 months. The analysis of vaginal discharge showed a restoration of an acid pH with the colonization of lactobacilli. No postoperative complications nor adverse events were recorded. CONCLUSIONS: The results of these first three cases pointed to autologous and micro-fragmented adipose tissue as a safe, feasible and effective therapeutic approach for the treatment of post-menopausal urogenital atrophy.
References0
Newest
Cited By3
Newest
#1Sheila Veronese (University of Verona)H-Index: 4
#2Elena Dai Prè (University of Verona)H-Index: 3
Last. Andrea Sbarbati (University of Verona)H-Index: 59
view all 6 authors...
Fat grafting is a well-established procedure in reconstructive, aesthetic, and regenerative medicine, in particular due to the presence in the adipose tissue of a high concentration of mesenchymal stem cells. The need to reduce fat processing times, for an immediate clinical use and regulatory restrictions on the degree of manipulation of human tissues have led to the development of numerous devices for the mechanical, non-enzymatic processing of adipose tissue. The aim of this study is to descr...
2 CitationsSource
#1Zinat Sarebani (QUMS: Qazvin University of Medical Sciences)H-Index: 1
#2Zainab Alimoradi (QUMS: Qazvin University of Medical Sciences)H-Index: 8
Last. Mark D. Griffiths (NTU: Nottingham Trent University)H-Index: 148
view all 7 authors...
Background: Menopause is associated with changes in sexual function which are partly due to vaginal atrophy in response to estrogen reduction. Estrogen administration temporarily reduces the symptoms of vaginal dryness, but long-term exposure to this drug is likely to be associated with serious complications. Considering the promising results of previous studies concerning the effect of vitamin D on vaginal dryness, the proposed study will investigate the effect of vitamin D vaginal suppository ...
1 CitationsSource
#1Sara NavaH-Index: 16
#2Valeria SordiH-Index: 23
Last. Giulio AlessandriH-Index: 48
view all 12 authors...
Over the last few years, human microfragmented adipose tissue (MFAT), containing significant levels of mesenchymal stromal cells (MSCs) and obtained from fat lipoaspirate (LP) through a minimal manipulation in a closed system device, has been successfully used in aesthetic medicine as well as in orthopedic and general surgery. Interestingly, in orthopedic diseases, this ready-to-use adipose tissue cell derivative seems to have a prolonged time efficacy even upon a single shot injection into oste...
13 CitationsSource